Skip to Content

b 859 (Flecainide Acetate 50 mg)

Pill with imprint b 859 is White, Round and has been identified as Flecainide Acetate 50 mg. It is supplied by Teva Pharmaceuticals USA.

Flecainide is used in the treatment of atrial fibrillation; atrial flutter; supraventricular tachycardia; wolff-parkinson-white syndrome; paroxysmal supraventricular tachycardia (and more), and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for b 859

Flecainide Acetate

Imprint:
b 859
Strength:
50 mg
Color:
White
Size:
7.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
corn starch
sodium stearyl fumarate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide